These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 14974125)

  • 1. Nuchal translucency and gestational age.
    Wald N; Rodeck C; Rudnicka A; Hackshaw A
    Prenat Diagn; 2004 Feb; 24(2):150-1. PubMed ID: 14974125
    [No Abstract]   [Full Text] [Related]  

  • 2. The distribution of nuchal translucency at 10-13 weeks of pregnancy.
    Schuchter K; Wald N; Hackshaw AK; Hafner E; Liebhart E
    Prenat Diagn; 1998 Mar; 18(3):281-6. PubMed ID: 9556045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-trimester increased nuchal translucency as a prenatal sign of Zellweger syndrome.
    Strenge S; Froster UG; Wanders RJ; Gartner J; Maier EM; Muntau AC; Faber R
    Prenat Diagn; 2004 Feb; 24(2):151-3. PubMed ID: 14974126
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nuchal translucency measurement in early diagnosis of Down syndrome].
    Saltvedt S; Bui TH
    Lakartidningen; 2001 Dec; 98(50):5762-5. PubMed ID: 11789099
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of nuchal translucency in contemporary obstetric practice.
    Said S; Malone FD
    Clin Obstet Gynecol; 2008 Mar; 51(1):37-47. PubMed ID: 18303498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural evolution of nuchal thickness in trisomy-21 fetuses.
    Borrell A; Costa D; Martinez JM; Farré MT; Cararach J; Fortuny A
    Obstet Gynecol; 1998 Jan; 91(1):78-81. PubMed ID: 9464725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First trimester nuchal translucency: effective routine screening for Down's syndrome.
    Thilaganathan B; Sairam S; Michailidis G; Wathen NC
    Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome.
    Wald NJ; Hackshaw AK
    Prenat Diagn; 1997 Sep; 17(9):821-9. PubMed ID: 9316126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison and integration of first trimester fetal nuchal translucency and second trimester maternal serum screening for fetal Down syndrome.
    Lam YH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF; Fong DY; Tang MH; Woo HH
    Prenat Diagn; 2002 Aug; 22(8):730-5. PubMed ID: 12210586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trimester Down Syndrome screening by nuchal translucency in a Thai population.
    Panburana P; Ajjimakorn S; Tungkajiwangoon P
    Int J Gynaecol Obstet; 2001 Dec; 75(3):311-2. PubMed ID: 11728495
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for nuchal translucency: expect or expedite?
    Herman A; Dreazen E
    Ultrasound Obstet Gynecol; 1996 Aug; 8(2):138. PubMed ID: 8883321
    [No Abstract]   [Full Text] [Related]  

  • 14. The 11-14 week scan.
    Nicolaides KH; Heath V; Liao AW
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Aug; 14(4):581-94. PubMed ID: 10985932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonography in the first trimester screening of trisomy 21 and other fetal aneuploidies.
    Brambati B; Tului L; Alberti E
    Early Pregnancy; 1996 Sep; 2(3):155-67. PubMed ID: 9363213
    [No Abstract]   [Full Text] [Related]  

  • 16. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter study.
    von Kaisenberg CS; Gasiorek-Wiens A; Bielicki M; Bahlmann F; Meyberg H; Kossakiewicz A; Pruggmayer M; Kamin G; Fritzer E; Harris C; Arnold N;
    J Matern Fetal Neonatal Med; 2002 Aug; 12(2):89-94. PubMed ID: 12420837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.
    Chasen ST; Sharma G; Kalish RB; Chervenak FA
    Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved methodology for evaluating nuchal thickness in the second trimester.
    Cadkin AV; Pergament E
    Prenat Diagn; 2002 Aug; 22(8):738-9. PubMed ID: 12210589
    [No Abstract]   [Full Text] [Related]  

  • 20. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency.
    Orlandi F; Damiani G; Hallahan TW; Krantz DA; Macri JN
    Ultrasound Obstet Gynecol; 1997 Dec; 10(6):381-6. PubMed ID: 9476320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.